Revolutionize The Way Drugs Are Discovered & Developed
Currently, it takes 12 years and $2.6 billion to get a single drug to market, with the drug discovery and development process costing $1.4 billion. At Verge Genomics, we believe there is a better way: we aim to improve the traditional drug discovery process with approaches based on systems biology, machine learning on human patient data, and drug screening in human cell cultures.
We’ve raised $32 million in Series A financing to build a next-generation biopharmaceutical company focused on accelerating development of life-saving treatments for patients with neurodegenerative diseases, including ALS, Parkinson’s Disease, and Alzheimer’s Disease.
Team of Founders – Ready to roll up our sleeves to get things done 💪🏽
Curiosity – Choose wonder over being right 🕵🏻♀️
Patient Focused – Inspired and driven by the people who need us ♥️
Transparency and Autonomy – Empowered to make decisions and express ourselves with candor 🗝
Growth Mindset – Treat every interaction as an opportunity to learn 🌱
Grit In the Face of Adversity -- Embrace challenges and persist against all odds
More About You
As an emerging startup, Verge Genomics provides growth opportunities into other areas of the company. Being one of the early employees at Verge, your work will have a direct impact on the foundation of a groundbreaking new drug development model. You will be empowered to own your work and makes real decisions.
In addition to competitive compensation and benefits, we offer perks like unlimited vacation/sick days, and free lunch delivered every day.